{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T18:14:51Z","timestamp":1761848091303,"version":"build-2065373602"},"reference-count":15,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Cardiovascular Interventions"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/j.jcin.2015.08.005","type":"journal-article","created":{"date-parts":[[2015,10,19]],"date-time":"2015-10-19T16:38:04Z","timestamp":1445272684000},"page":"1571-1573","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Prasugrel in Clopidogrel Nonresponders"],"prefix":"10.1016","volume":"8","author":[{"given":"Kurt","family":"Huber","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcin.2015.08.005_bib1","first-page":"517","volume":"46","author":"Kolh","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jcin.2015.08.005_bib2","first-page":"1725","article-title":"Canadian ACS\u00a0Reflective Group. Increased uptake of guideline-recommended oral antiplatelet therapy: insights from the Canadian acute coronary syndrome reflective","volume":"30","author":"Gandhi","year":"2014","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.jcin.2015.08.005_bib3","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1016\/j.jcin.2015.07.010","article-title":"Prasugrel in clopidogrel nonresponders undergoing percutaneous coronary intervention: the RECLOSE-3 study (REsponsiveness to CLOpidogrel and StEnt Thrombosis)","volume":"8","author":"Valenti","year":"2015","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"key":"10.1016\/j.jcin.2015.08.005_bib4","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1093\/eurheartj\/eht375","article-title":"Working Group on Thrombosis of the European Society of Cardiology. Expert position paper on the role of platelet function testing in patients undergoing percutaneous coronary intervention","volume":"35","author":"Aradi","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jcin.2015.08.005_bib5","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1160\/TH14-05-0449","article-title":"Working Group on Thrombosis of the European Society of Cardiology. Platelet function testing in acute cardiac care: is there a role for prediction or prevention of stent thrombosis and bleeding?","volume":"113","author":"Aradi","year":"2015","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jcin.2015.08.005_bib6","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1161\/CIRCINTERVENTIONS.114.001555","article-title":"In-hospital switching between clopidogrel and prasugrel among patients with acute myocardial infarction treated with percutaneous coronary intervention: insights into contemporary practice from the national cardiovascular data registry","volume":"7","author":"Bagai","year":"2014","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.jcin.2015.08.005_bib7","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.jcin.2015.03.023","article-title":"COMFORTABLE and SPUM-ACS Trial Investigators. Safety of prasugrel loading doses in patients pre-loaded with clopidogrel in the setting of primary percutaneous coronary intervention: results of a nonrandomized observational study","volume":"8","author":"R\u00e4ber","year":"2015","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"key":"10.1016\/j.jcin.2015.08.005_bib8","doi-asserted-by":"crossref","DOI":"10.3109\/09537104.2015.1042447","article-title":"Switching from clopidogrel to prasugrel in patients undergoing PCI: a meta-analytic overview","author":"Verdoia","year":"2015","journal-title":"Platelets"},{"key":"10.1016\/j.jcin.2015.08.005_bib9","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1001\/jama.2011.290","article-title":"Standard- vs high-dose clopidogrel based on platelet function\u00a0testing after percutaneous coronary intervention: the GRAVITAS randomized trial","volume":"305","author":"Price","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.jcin.2015.08.005_bib10","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1056\/NEJMoa1209979","article-title":"ARCTIC Investigators. Bedside monitoring to adjust antiplatelet therapy for coronary stenting","volume":"367","author":"Collet","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jcin.2015.08.005_bib11","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1016\/j.jacc.2012.02.026","volume":"59","author":"Trenk","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2015.08.005_bib12","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1160\/TH13-10-0874","article-title":"A\u00a0comparative cohort study on personalised antiplatelet therapy in PCI-treated patients with high on-clopidogrel platelet reactivity. Results of the ISAR-HPR registry","volume":"112","author":"Mayer","year":"2014","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jcin.2015.08.005_bib13","doi-asserted-by":"crossref","first-page":"547","DOI":"10.5603\/CJ.a2014.0026","article-title":"Prasugrel overcomes high on-clopidogrel platelet reactivity in the acute phase of acute coronary syndrome and maintains its antiplatelet potency at 30-day follow-up","volume":"21","author":"Kozi\u0144ski","year":"2014","journal-title":"Cardiol J"},{"key":"10.1016\/j.jcin.2015.08.005_bib14","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1160\/TH09-07-0482","article-title":"Prasugrel compared with high-dose clopidogrel in acute coronary syndrome. The randomised, double-blind ACAPULCO study","volume":"103","author":"Montalescot","year":"2010","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jcin.2015.08.005_bib15","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.ijcard.2015.06.016","article-title":"A pharmacodynamic comparison of a personalized strategy for anti-platelet therapy versus ticagrelor in achieving a therapeutic window","volume":"197","author":"Malhotra","year":"2015","journal-title":"Int J Cardiol"}],"container-title":["JACC: Cardiovascular Interventions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S193687981501239X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S193687981501239X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T18:01:22Z","timestamp":1761847282000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S193687981501239X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":15,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["S193687981501239X"],"URL":"https:\/\/doi.org\/10.1016\/j.jcin.2015.08.005","relation":{},"ISSN":["1936-8798"],"issn-type":[{"type":"print","value":"1936-8798"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prasugrel in Clopidogrel Nonresponders","name":"articletitle","label":"Article Title"},{"value":"JACC: Cardiovascular Interventions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcin.2015.08.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.jcin.2015.07.010","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}